A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer

Purpose: Pre-operative chemoradiation (CRT) is currently the standard of care for patients with clinical stage II and III rectal cancer but only about 45% of patients achieve tumor downstaging and <20% of patients achieve a pathologic complete response. Better methods to stratify patients accordi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jason, Kinsella, Michael T., Willis, Joseph E., Hu, Huankai, Reynolds, Harry, Delaney, Conor, McCulla, Andrea, Deharo, Steve, Ahdesmäki, Miika, Allen, Wendy Louise, Johnston, Patrick G., Kinsella, Timothy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839295/
https://www.ncbi.nlm.nih.gov/pubmed/24324931
http://dx.doi.org/10.3389/fonc.2013.00288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839295/
https://www.ncbi.nlm.nih.gov/pubmed/24324931
http://dx.doi.org/10.3389/fonc.2013.00288

Ejemplares similares